CDKN2A and neoplasm: For IDH-mut astrocytomas, the presence of CDKN2A/B homozygous deletion now classifies the tumor as a WHO grade 4 astrocytoma, even in the absence of histopathological features of necrosis and microvascular proliferation (10).